skip to main content

Synthesis of 1-Hydroxy-6-methoxyxanthone and Comparison of Its α-Glucosidase Inhibitory and Antibacterial Activities with Hydroxyxanthone Derivatives

1Chemistry Education, Sultan Ageng Tirtayasa University, Serang, Banten 42117, Indonesia

2Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Tangerang Selatan, Banten 15314, Indonesia

3Department of Chemistry, Faculty of Military Mathematics and Natural Sciences, Universitas Pertahanan Republik Indonesia, Bogor 16810, Indonesia

4 Department of Chemistry, Universitas Negeri Semarang, Kampus Sekaran, Gunungpati, Semarang 50229, Indonesia

5 Chemistry Department, Faculty of Sciences and Mathematics, Diponegoro University, Jl. Prof. Soedarto, SH., Tembalang, Semarang, Indonesia

View all affiliations
Received: 21 Aug 2026; Revised: 16 Sep 2026; Accepted: 9 Oct 2026; Published: 30 Oct 2026.
Open Access Copyright 2026 Jurnal Kimia Sains dan Aplikasi under http://creativecommons.org/licenses/by-sa/4.0.

Citation Format:
Cover Image
Abstract

Xanthone derivatives have attracted considerable interest owing to their broad spectrum of biological activities, making them promising scaffolds for the development of multifunctional therapeutic agents. In this study, 1-hydroxy-6-methoxyxanthone (MX1) was synthesized via cyclodehydration using Eaton’s reagent, affording the target compound in 18.50% yield, and structurally characterized by FTIR, LC–MS, and NMR spectroscopy. MX1 was obtained as a yellow solid in 18.50% yield, with a melting point of 145–147°C. The α- glucosidase inhibitory and antibacterial activities of MX1 were evaluated in comparison with those of previously reported hydroxyxanthone derivatives (HX1–HX3), while molecular docking was performed to investigate their binding interactions with α-glucosidase. Among the evaluated compounds, MX1 exhibited the most potent α-glucosidase inhibitory activity with an IC50 value of 203.23 μg/mL, followed by HX2 (223.53 μg/mL), whereas HX1 and HX3 showed weaker inhibition, with IC50 values of 463.74 and 482.86 μg/mL, respectively. Molecular docking demonstrated that all compounds occupied a common binding pocket and formed favorable interactions with key active-site residues through hydrogen bonding, π–π, and π–anion interactions, supporting the proposed structure–activity relationships. In contrast, MX1 exhibited limited antibacterial activity, with MIC values of 500 μg/mL against Pseudomonas aeruginosa and Bacillus subtilis and >1000 μg/mL against Escherichia coli and Staphylococcus aureus. Collectively, these findings indicate that replacement of the C-6 hydroxyl group with a methoxy group enhances α-glucosidase inhibitory activity while reducing antibacterial activity, underscoring the pivotal role of C-6 substitution in modulating the biological activities of xanthone derivatives.

Keywords: Antibacterial activity; Molecular docking; Synthesis; 1-Hydroxy-6-methoxyxanthone; α- Glucosidase inhibition
Funding: Universitas Sultan Ageng Tirtayasa

Article Metrics:

  1. D. Tomic, J. E. Shaw, D. J. Magliano, The burden and risks of emerging complications of diabetes mellitus, Nature Reviews Endocrinology, 18, 9, (2022), 525-539 https://doi.org/10.1038/s41574-022-00690-7
  2. U. Hossain, A. K. Das, S. Ghosh, P. C. Sil, An overview on the role of bioactive α-glucosidase inhibitors in ameliorating diabetic complications, Food and Chemical Toxicology, 145, (2020), 111738 https://doi.org/10.1016/j.fct.2020.111738
  3. M. Alssema, C. Ruijgrok, E. E. Blaak, L. Egli, P. Dussort, S. Vinoy, J. M. Dekker, M. Denise Robertson, Effects of alpha-glucosidase-inhibiting drugs on acute postprandial glucose and insulin responses: a systematic review and meta-analysis, Nutrition & Diabetes, 11, (2021), 11 https://doi.org/10.1038/s41387-021-00152-5
  4. S. R. Dehkordi, N. Pahlavani, M. Nikbaf-Shandiz, R. Bagheri, N. Rasaei, M. Darzi, S. Rastgoo, H. Bahari, F. Shiraseb, O. Asbaghi, A systematic review, meta-analysis, dose-response, and meta-regression of the effects of acarbose intake on glycemic markers in adults, Journal of Diabetes & Metabolic Disorders, 23, (2024), 135-172 https://doi.org/10.1007/s40200-023-01336-9
  5. C. J. L. Murray, K. S. Ikuta, F. Sharara, L. Swetschinski, G. Robles Aguilar, A. Gray, C. Han, C. Bisignano, P. Rao, E. Wool, S. C. Johnson, A. J. Browne, M. G. Chipeta, F. Fell, S. Hackett, G. Haines-Woodhouse, B. H. Kashef Hamadani, E. A. P. Kumaran, B. McManigal, M. Naghavi, Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis, The Lancet, 399, 10325, (2022), 629-655 https://doi.org/10.1016/S0140-6736(21)02724-0
  6. C. R. MacNair, S. T. Rutherford, M. W. Tan, Alternative therapeutic strategies to treat antibiotic-resistant pathogens, Nature Reviews Microbiology, 22, (2024), 262-275 https://doi.org/10.1038/s41579-023-00993-0
  7. M. U. Azmi, N. I. Ramadhan, H. Margasari, F. N. Sari, L. N. Fitriani, T. S. Tjahjandarie, M. Tanjung, R. D. Saputri, Xanthone Derivatives from the Twigs of Garcinia hombroniana L. and Their Antioxidant Activity, Tropical Journal of Natural Product Research, 10, 5, (2026), 9476-9481 https://doi.org/10.26538/tjnpr/v10i5.63
  8. Z. Feng, X. Lu, L. Gan, Q. Zhang, L. Lin, Xanthones, A Promising Anti-Inflammatory Scaffold: Structure, Activity, and Drug Likeness Analysis, Molecules, 25, 3, (2020), 598 https://doi.org/10.3390/molecules25030598
  9. H. Li, W. T. Kang, Y. Zheng, Y. He, R. Zhong, S. Fang, W. Wen, S. Liu, S. Lin, Development of xanthone derivatives as effective broad-spectrum antimicrobials: Disrupting cell wall and inhibiting DNA synthesis, Science Advances, 11, 10, (2025), https://doi.org/10.1126/sciadv.adt4723
  10. R. Saikia, K. Pathak, P. Pramanik, M. A. Islam, S. Karmakar, S. Gogoi, M. P. Pathak, D. Das, J. J. Sahariah, M. Z. Ahmad, A. Das, Exploring the therapeutic potential of xanthones in diabetes management: Current insights and future directions, European Journal of Medicinal Chemistry Reports, 12, (2024), 100189 https://doi.org/10.1016/j.ejmcr.2024.100189
  11. G. Zhou, K. Dong, X. Xu, R. Guo, G. Li, J. Wang, L. Zhou, S. Yuan, H. Lou, H. Li, H. Dong, X. Peng, Fungal dimeric xanthones as anticancer agents by novelly stimulating sodium-calcium exchanger 1, European Journal of Medicinal Chemistry, 290, (2025), 117543 https://doi.org/10.1016/j.ejmech.2025.117543
  12. M. M. M. Pinto, A. Palmeira, C. Fernandes, D. I. S. P. Resende, E. Sousa, H. Cidade, M. E. Tiritan, M. Correia-Da-silva, S. Cravo, From Natural Products to New Synthetic Small Molecules: A Journey through the World of Xanthones, Molecules, 26, 2, (2021), 431 https://doi.org/10.3390/molecules26020431
  13. Y. Liu, L. Zou, L. Ma, W. H. Chen, B. Wang, Z. Le Xu, Synthesis and pharmacological activities of xanthone derivatives as α-glucosidase inhibitors, Bioorganic & Medicinal Chemistry, 14, 16, (2006), 5683-5690 https://doi.org/10.1016/j.bmc.2006.04.014
  14. E. Yuanita, I. M. Sudarma, N. M. Sudewiningsih, J. Syahri, N. K. T. Dharmayani, Sudirman, M. Ulfa, I. Sumarlan, Antibacterial activity and molecular docking studies of series hydroxyxanthone, The 8th International Conference of The Indonesian Chemical Society (ICICS) 2019, Bogor, Indonesia, 2020 https://doi.org/10.1063/5.0001090
  15. E. Fachriyah, M. B. Huda, P. R. Sarjono, F. Hermawan, R. S. Lase, N. Wijayati, J. Jumina, Y. D. Kurniawan, M. E. Prastya, Synthesis, Antibacterial Activity, and In Silico Analysis of Hydroxyxanthone Derivatives Targeting Gram-Positive and Gram-Negative Bacteria, Indonesian Journal of Chemistry, 26, 3, (2026), 948-962 https://doi.org/10.22146/ijc.113042
  16. L. Wang, C. Ai, C. Jin, J. Mou, Y. Deng, Xanthones as potential α-glucosidase non-competition inhibitors: Synthesis, inhibitory activities, and in silico studies, Chemical Biology & Drug Design, 102, 3, (2023), 547-556 https://doi.org/10.1111/cbdd.14272
  17. D. N. A. A. Heilman, A. Y. C. Hui, V. J. Y. Mian, F. B. Ahmad, L. P. Cee, J. Stanslas, N. H. Zamakshshari, Unlocking the Antibacterial Potential of Xanthone from Calophyllum Species: Inhibition of Nucleic Acid Synthesis, Chemistry Select, 8, 46, (2023), e202302737 https://doi.org/10.1002/slct.202302737
  18. I. P. A. H. Wibawa, F. Xavier, H. Verlianni, M. Minarti, P. D. Lotulung, M. Hanafi, Pinanga arinasae Witono, an endangered plant native to Bali, potentially as an antidiabetic and antioxidant, Natural Product Research, (2026), 1-5 https://doi.org/10.1080/14786419.2026.2632384
  19. E. N. W. Hening, J. A. Priyanto, M. E. Prastya, R. I. Astuti, L. O. A. P. Hasidu, Jamilah, Soil bacteria from Muna Island, Southeast Sulawesi, Indonesia: Antibacterial and antibiofilm activities, and the presence of antibiotic-biosynthetic genes, Journal of Applied Pharmaceutical Sciences, 14, 6, (2024), 207-217 https://doi.org/10.7324/japs.2024.171508
  20. M. D. Hanwell, D. E. Curtis, D. C. Lonie, T. Vandermeersch, E. Zurek, G. R. Hutchison, Avogadro: an advanced semantic chemical editor, visualization, and analysis platform, Journal of Cheminformatics, 4, (2012), 17 https://doi.org/10.1186/1758-2946-4-17
  21. F. Neese, F. Wennmohs, U. Becker, C. Riplinger, The ORCA quantum chemistry program package, Journal of Chemical Physics, 152, 22, (2020), 224108 https://doi.org/10.1063/5.0004608
  22. E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. Ferrin, UCSF Chimera—A visualization system for exploratory research and analysis, Journal of Computational Chemistry, 25, 13, (2004), 1605-1612 https://doi.org/10.1002/jcc.20084
  23. G. M. Morris, H. Ruth, W. Lindstrom, M. F. Sanner, R. K. Belew, D. S. Goodsell, A. J. Olson, AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility, Journal of Computational Chemistry, 30, 16, (2009), 2785-2791 https://doi.org/10.1002/jcc.21256
  24. Biovia Dassault Systèmes, Discovery Studio Visualizer (21.1.0.20298), Dassault Systèmes, 2021,
  25. J. Bosson, Scope and limitations of the preparation of xanthones using Eaton’s reagent, Turkish Journal of Chemistry, 47, 6, (2023), 1420-1428 https://doi.org/10.55730/1300-0527.3624
  26. G. Granados-Guzmán, R. Castro-Ríos, N. Waksman de Torres, R. Salazar-Aranda, Optimization and Validation of a Microscale In vitro Method to Assess α-Glucosidase Inhibition Activity, Current Analytical Chemistry, 14, 5, (2018), 458-464 https://doi.org/10.2174/1573411013666170911154755
  27. J. Li, A. Fu, L. Zhang, An Overview of Scoring Functions Used for Protein–Ligand Interactions in Molecular Docking, Interdisciplinary Sciences: Computational Life Sciences, 11, (2019), 320-328 https://doi.org/10.1007/s12539-019-00327-w
  28. G. L. Warren, C. W. Andrews, A. M. Capelli, B. Clarke, J. LaLonde, M. H. Lambert, M. Lindvall, N. Nevins, S. F. Semus, S. Senger, G. Tedesco, I. D. Wall, J. M. Woolven, C. E. Peishoff, M. S. Head, A Critical Assessment of Docking Programs and Scoring Functions, Journal of Medicinal Chemistry, 49, 20, (2006), 5912-5931 https://doi.org/10.1021/jm050362n
  29. S. Y. Huang, S. Z. Grinter, X. Zou, Scoring functions and their evaluation methods for protein–ligand docking: recent advances and future directions, Physical Chemistry Chemical Physics, 12, 40, (2010), 12899–12908 https://doi.org/10.1039/c0cp00151a

Last update:

No citation recorded.

Last update: 2026-11-05 16:37:41

No citation recorded.